The decrease in breast-cancer incidence in 2003 in the United States
- PMID: 17442911
- DOI: 10.1056/NEJMsr070105
The decrease in breast-cancer incidence in 2003 in the United States
Abstract
An initial analysis of data from the National Cancer Institute's Surveillance, Epidemiology, and End Results (SEER) registries shows that the age-adjusted incidence rate of breast cancer in women in the United States fell sharply (by 6.7%) in 2003, as compared with the rate in 2002. Data from 2004 showed a leveling off relative to the 2003 rate, with little additional decrease. Regression analysis showed that the decrease began in mid-2002 and had begun to level off by mid-2003. A comparison of incidence rates in 2001 with those in 2004 (omitting the years in which the incidence was changing) showed that the decrease in annual age-adjusted incidence was 8.6% (95% confidence interval [CI], 6.8 to 10.4). The decrease was evident only in women who were 50 years of age or older and was more evident in cancers that were estrogen-receptor-positive than in those that were estrogen-receptor-negative. The decrease in breast-cancer incidence seems to be temporally related to the first report of the Women's Health Initiative and the ensuing drop in the use of hormone-replacement therapy among postmenopausal women in the United States. The contributions of other causes to the change in incidence seem less likely to have played a major role but have not been excluded.
Copyright 2007 Massachusetts Medical Society.
Comment in
-
A decline in breast-cancer incidence.N Engl J Med. 2007 Aug 2;357(5):509; author reply 513. doi: 10.1056/NEJMc071391. N Engl J Med. 2007. PMID: 17671264 No abstract available.
-
A decline in breast-cancer incidence.N Engl J Med. 2007 Aug 2;357(5):511; author reply 513. N Engl J Med. 2007. PMID: 17674459 No abstract available.
-
A decline in breast-cancer incidence.N Engl J Med. 2007 Aug 2;357(5):511-2; author reply 513. N Engl J Med. 2007. PMID: 17674460 No abstract available.
-
A decline in breast-cancer incidence.N Engl J Med. 2007 Aug 2;357(5):512-3; author reply 513. N Engl J Med. 2007. PMID: 17674461 No abstract available.
-
A decline in breast-cancer incidence.N Engl J Med. 2007 Aug 2;357(5):510-1; author reply 513. N Engl J Med. 2007. PMID: 17674462 No abstract available.
-
A decline in breast-cancer incidence.N Engl J Med. 2007 Aug 2;357(5):509; author reply 513. N Engl J Med. 2007. PMID: 17674463 No abstract available.
-
A decline in breast-cancer incidence.N Engl J Med. 2007 Aug 2;357(5):509-10; author reply 513. N Engl J Med. 2007. PMID: 17674464 No abstract available.
Similar articles
-
Trends in incidence rates of invasive lobular and ductal breast carcinoma.JAMA. 2003 Mar 19;289(11):1421-4. doi: 10.1001/jama.289.11.1421. JAMA. 2003. PMID: 12636465
-
Breast cancer incidence and hormone replacement therapy in Canada.J Natl Cancer Inst. 2010 Oct 6;102(19):1489-95. doi: 10.1093/jnci/djq345. Epub 2010 Sep 23. J Natl Cancer Inst. 2010. PMID: 20864685
-
Recent trends in breast cancer incidence rates by age and tumor characteristics among U.S. women.Breast Cancer Res. 2007;9(3):R28. doi: 10.1186/bcr1672. Breast Cancer Res. 2007. PMID: 17477859 Free PMC article.
-
Annual report to the nation on the status of cancer, 1975-2000, featuring the uses of surveillance data for cancer prevention and control.J Natl Cancer Inst. 2003 Sep 3;95(17):1276-99. doi: 10.1093/jnci/djg040. J Natl Cancer Inst. 2003. PMID: 12953083 Review.
-
Is the decrease in breast cancer incidence related to a decrease in postmenopausal hormone therapy?Ann N Y Acad Sci. 2010 Sep;1205:268-76. doi: 10.1111/j.1749-6632.2010.05664.x. Ann N Y Acad Sci. 2010. PMID: 20840283 Review.
Cited by
-
Trends and variations in breast and colorectal cancer incidence from 1995 to 2011: a comparative study between Texas Cancer Registry and National Cancer Institute's Surveillance, Epidemiology and End Results data.Int J Oncol. 2015 Apr;46(4):1819-26. doi: 10.3892/ijo.2015.2881. Epub 2015 Feb 6. Int J Oncol. 2015. PMID: 25672365 Free PMC article.
-
Decline in breast cancer incidence due to removal of promoter: combination estrogen plus progestin.Breast Cancer Res. 2007;9(4):108. doi: 10.1186/bcr1736. Breast Cancer Res. 2007. PMID: 17666116 Free PMC article.
-
A case-control study of levothyroxine and the risk of colorectal cancer.J Natl Cancer Inst. 2010 Apr 21;102(8):568-72. doi: 10.1093/jnci/djq042. Epub 2010 Mar 19. J Natl Cancer Inst. 2010. PMID: 20305129 Free PMC article.
-
Dual-Outcome Intention-to-Treat Analyses in the Women's Health Initiative Randomized Controlled Hormone Therapy Trials.Am J Epidemiol. 2020 Sep 1;189(9):972-981. doi: 10.1093/aje/kwaa033. Am J Epidemiol. 2020. PMID: 32314781 Free PMC article.
-
Age-related crossover in breast cancer incidence rates between black and white ethnic groups.J Natl Cancer Inst. 2008 Dec 17;100(24):1804-14. doi: 10.1093/jnci/djn411. Epub 2008 Dec 9. J Natl Cancer Inst. 2008. PMID: 19066264 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical